Top compounds associated with response to RDH8


Feature Type Standardized
Nominal ANOVA
mRNA Zebularine CTRPv2 pan-cancer AAC -0.083 0.01
mRNA Irinotecan gCSI pan-cancer AAC -0.13 0.01
mRNA selumetinib:MK-2206 (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.085 0.01
mRNA paclitaxel CCLE pan-cancer AAC -0.11 0.01
mRNA ML311 CTRPv2 pan-cancer AAC -0.076 0.02
mRNA AT13387 CTRPv2 pan-cancer AAC -0.11 0.02
mRNA tivantinib CTRPv2 pan-cancer AAC -0.1 0.02
mRNA BRD9876:MK-1775 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.25 0.02
mRNA GSK1120212 CTRPv2 pan-cancer AAC 0.11 0.02
mRNA narciclasine CTRPv2 pan-cancer AAC -0.077 0.02
Download CSV